MetLife Investment Management’s MiMedx Group MDXG Stock Holding History

MetLife Investment Management’s Portfolio MDXG Stock Details MDXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$213K	Sell	53,991 -10,819	-17%	-$54.5K	﹤0.01%	2190
2025 Q4	$439K	Sell	64,810 -6,185	-9%	-$43.4K	﹤0.01%	1854
2025 Q3	$496K	Hold	70,995	–	–	﹤0.01%	1811
2025 Q2	$434K	Buy	70,995 +2,233	+3%	+$14.9K	﹤0.01%	1743
2025 Q1	$523K	Sell	68,762 -4,544	-6%	-$38K	﹤0.01%	1706
2024 Q4	$705K	Buy	73,306 +6,673	+10%	+$52K	﹤0.01%	1603
2024 Q3	$394K	Hold	66,633	–	–	﹤0.01%	1910
2024 Q2	$462K	Buy	66,633 +11,901	+22%	+$83.7K	﹤0.01%	1759
2024 Q1	$421K	Sell	54,732 -5,261	-9%	-$42.3K	﹤0.01%	1772
2023 Q4	$526K	Hold	59,993	–	–	﹤0.01%	1659
2023 Q3	$437K	Hold	59,993	–	–	﹤0.01%	1712
2023 Q2	$397K	Hold	59,993	–	–	﹤0.01%	1855
2023 Q1	$205K	Buy	59,993 +11,153	+23%	+$43.2K	﹤0.01%	2209
2022 Q4	$136K	Sell	48,840 -13,023	-21%	-$38.9K	﹤0.01%	2464
2022 Q3	$178K	Buy	61,863 +7,298	+13%	+$25.9K	﹤0.01%	2372
2022 Q2	$189K	Sell	54,565 -8,246	-13%	-$32.3K	﹤0.01%	2360
2022 Q1	$296K	Buy	62,811 +22,593	+56%	+$110K	﹤0.01%	2105
2021 Q4	$243K	Buy	40,218 +13,960	+53%	+$96.9K	﹤0.01%	1940
2021 Q3	$159K	Sell	26,258 -14,876	-36%	-$168K	﹤0.01%	2225
2021 Q2	$515K	Buy	+41,134	New	+$445K	﹤0.01%	1550
2018 Q4	–	Sell	-48,233	Closed	-$298K	–	2585
2018 Q3	$298K	Hold	48,233	–	–	﹤0.01%	1860
2018 Q2	$308K	Hold	48,233	–	–	﹤0.01%	1706
2018 Q1	$336K	Hold	48,233	–	–	﹤0.01%	1622
2017 Q4	$608K	Buy	+48,233	New	+$588K	0.01%	1291

Other funds holding MDXG

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Trigran Investments Northbrook, Illinois $418M AUM 3.34% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

MetLife Investment Management's MDXG Position: Q1 2026 in Review

MetLife Investment Management reduced its MiMedx Group (MDXG) stake by 17% in Q1 2026, selling an estimated $54.5K and leaving 53,991 shares worth $213K. The position accounts for ﹤0.01% of the portfolio, ranked #2190.

MetLife Investment Management first reported a position in MDXG in Q4 2017 and has held it in 24 quarters since. The position peaked at $705K in Q4 2024. 237 funds tracked by Wall St. Rank hold MDXG as of Q1 2026.

MetLife Investment Management held 53,991 shares of MiMedx Group worth $213K as of Q1 2026.
MetLife Investment Management sold 10,819 MiMedx Group shares in Q1 2026, an estimated $54.5K.
MiMedx Group made up ﹤0.01% of MetLife Investment Management's portfolio in Q1 2026, its #2190 holding.
MetLife Investment Management first reported a position in MiMedx Group in Q4 2017 and has held it in 24 quarters since.
MetLife Investment Management's MiMedx Group position peaked at $705K in Q4 2024.
237 funds tracked by Wall St. Rank held MiMedx Group as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.